ORION Corp. (KRX:271560)
103,600
+1,900 (1.87%)
At close: Nov 7, 2025
ORION Revenue
ORION had revenue of 777.17B KRW in the quarter ending June 30, 2025, with 8.05% growth. This brings the company's revenue in the last twelve months to 3.22T, up 7.10% year-over-year. In the year 2024, ORION had annual revenue of 3.10T with 6.59% growth.
Revenue (ttm)
3.22T
Revenue Growth
+7.10%
P/S Ratio
1.27
Revenue / Employee
2.19B
Employees
1,471
Market Cap
4.10T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.10T | 191.98B | 6.59% |
| Dec 31, 2023 | 2.91T | 39.11B | 1.36% |
| Dec 31, 2022 | 2.87T | 517.75B | 21.98% |
| Dec 31, 2021 | 2.36T | 125.68B | 5.64% |
| Dec 31, 2020 | 2.23T | 206.52B | 10.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CJ Cheiljedang | 29.35T |
| LOTTE | 15.54T |
| LG H&H | 6.63T |
| KT&G Corporation | 6.23T |
| AMOREPACIFIC Holdings | 4.51T |
| Amorepacific | 4.14T |
| Nongshim | 3.47T |
| Cosmax | 2.30T |
ORION News
- 4 months ago - Orion Corporation's financial reporting and Annual General Meeting in 2026 - Benzinga
- 6 months ago - Shilpa Medicare subsidiary partners with Orion Corporation to commercialize Recombinant Human Albumin in Europe - Business Upturn